(Q46077959)

19 December 2017

title

Hormone replacement therapy is associated with improved survival in women with advanced heart failure (English)

1 reference

19 December 2017

Hormone Replacement Therapy

main subject

1 reference

12

1 reference

19 December 2017

Clyde Yancy

8

object named as

Clyde Yancy

1 reference

19 December 2017

7

Mary Ann Peberdy

1 reference

19 December 2017

JoAnn Lindenfeld

1

1 reference

19 December 2017

Jalal K Ghali

2

1 reference

19 December 2017

Heidi J Krause-Steinrauf

3

1 reference

19 December 2017

Steven Khan

4

1 reference

19 December 2017

Kirkwood Adams

5

1 reference

19 December 2017

Steven Goldman

6

1 reference

19 December 2017

Surai Thaneemit-Chen

9

1 reference

19 December 2017

Rhonda L Larsen

10

1 reference

19 December 2017

James Young

11

1 reference

19 December 2017

Yves D Rosenberg

13

1 reference

19 December 2017

BEST Investigators

14

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

19 December 2017

Journal of the American College of Cardiology

published in

1 reference

19 December 2017

volume

42

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1238-1245

1 reference

19 December 2017

The epidemiology of heart failure: the Framingham Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Acute vascular effects of estrogen in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Prognostic value of plasma endothelin-1 in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Adrenergic nervous system in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Sex differences in cardiac adaptation to essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Effect of hormone replacement therapy on left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Sex differences in cardiac adaptation to isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Sex-associated differences in left ventricular function in aortic stenosis of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Alterations of cardiac performance in rats with established spontaneous hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences in molecular remodeling in pressure overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Cardiac myocytes and fibroblasts contain functional estrogen receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

17beta-estradiol attenuates the development of pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Gender differences and aging: effects on the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Myocardial Akt activation and gender: increased nuclear activity in females versus males

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

The relationship of treatment adherence to the risk of death after myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

Fixing the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900938-0

7 January 2021

10.1016/S0735-1097(03)00938-0

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017